Provider review
Rx.com review: it names the pharmacy, the street and the doctors, and promises nothing about your weight
Two questions almost nothing in this market answers: who fills my prescription, and can I take it somewhere else? Rx.com answers both, in its own terms, with a pharmacy name, a street address and a phone number — and a line saying you may send the prescription to any pharmacy you like. Its GLP-1 pages also make no promise about weight at all. No percentage, no timeline, no before-and-after. The loudest numbers on the site belong to a discount card that has nothing to do with the drug.
Names the pharmacy, its street and the clinical network, and makes no claim about your weight anywhere on the site.
Worth trusting if
- You want to know which pharmacy fills your prescription, and to look it up before you pay
- You want the option of sending the prescription to your own pharmacy instead
- You want a seller that describes the drug rather than promising you a result
Be skeptical if
- You want published evidence beside the claims, because no trial is named anywhere on the site
- You want to know whether your medication is made to order or dispensed ready-made
- You arrived from the discount card, whose percentages have nothing to do with this program
Compounded only
Phase 3 trials
Named
None found
Disclosure: Some links on this site are affiliate or referral links. If you start a treatment or buy a product through them, we may earn a commission at no additional cost to you. Read our full disclosure.
Opens rx.com. A link is not a recommendation to take anything.
Provenance
What Rx.com actually dispenses
Regulatory category is the axis consumers are most reliably misled about, so it comes first. Every product below is sorted by what it legally is, not by what it costs.
Prepared by a state-licensed pharmacy against a prescription for a named patient. Compounded preparations are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
- Compounded semaglutide injection — $175 for a single month; the advertised $146 needs six months paid at once.
- Compounded tirzepatide injection — $285 for a single month; $259 on the six-month plan.
Evidence
Has the molecule been tested for what it is sold for?
One row per product, graded on how far the published human evidence goes for the MOLECULE inside it, for the use it is sold for — not for the molecule in general, and never a claim about this seller. Nobody trials a compounded preparation; what a trial can tell you is whether the molecule has been tested for the thing it is being advertised to do. A molecule with phase 3 evidence for one outcome has none for another, and that distinction is where peptide marketing lives.
2
Molecules with human evidence
For the use they are sold for, out of 2 products reviewed here. The evidence belongs to the molecule, not to Rx.com.
2
Registry records cited
Each read live from ClinicalTrials.gov, never from memory. None of them tested this company's product.
The comparison
What they claim, against what the trials show
Each claim below is quoted verbatim from Rx.com’s own page, with the page it came from. Grading a paraphrase would prove nothing. Every row is the verdict at a glance — tap it to open the quote, the trial registry entries, and the full note behind that verdict.
Compounded semaglutide injectionSemaglutide · Compounded (503A)Claim matches the trials
“The most widely used GLP-1. A strong first choice if you are new to GLP-1 medication or want the lowest monthly cost. Same price at every dose. We never charge by strength. Your provider sets and adjusts your dose (0.25 mg to 2.4 mg).”
Read on the Rx.com site, September 2026
Phase 3 trials
What the trials show for Semaglutide
- NCT03548935 STEP 1 — Phase 3, completed, n=1,961. 68 weeks in 1,961 adults, titrated to semaglutide 2.4 mg — the same ceiling Rx.com names on its own page. Reported a mean weight reduction of about 15%.
Nothing on this page says what the drug will do to your weight, so there is no outcome claim to weigh. What it does say about the molecule is factually careful in a way that is easy to miss: the dose range it publishes, 0.25 mg to 2.4 mg, is exactly the ladder STEP 1 titrated participants along, ending at the 2.4 mg maintenance dose the trial measured. A seller quoting a ceiling that matches the trial is a small thing and a good sign, because the common failure is an advertised price pegged to a starting dose with no ladder published above it. The description of semaglutide as the most widely used GLP-1 is a market claim rather than a clinical one and is not graded here.1
Compounded tirzepatide injectionTirzepatide · Compounded (503A)Claim matches the trials
“Works on two hormone receptors, GLP-1 and GIP. Produced the largest average weight loss in its clinical trials. Your provider sets and adjusts your dose (2.5 mg to 15 mg); your price stays the same.”
Read on the Rx.com site, September 2026
Phase 3 trials
What the trials show for Tirzepatide
- NCT04184622 SURMOUNT-1 — Phase 3, completed, n=2,539. 72 weeks in 2,539 adults at 5, 10 and 15 mg once weekly, from a 2.5 mg starting dose. Reported a mean reduction of roughly 20% at the top dose — the largest published for an approved medicine in this class.
Two claims here and both survive. That tirzepatide acts on two receptors is a correct description of the molecule. That it produced the largest average weight loss in its trials is supported by SURMOUNT-1 among approved medicines in this class, and Rx.com scopes it properly — the sentence says in its clinical trials, not in all trials of everything. The dose range it publishes, 2.5 mg to 15 mg, again matches the trial ladder exactly. What is missing is a citation: no trial, journal or year appears anywhere on the site, so a reader has nothing to check it against. That is unsourced, not wrong.2
Dispensing chain
Who actually fills your prescription
- Manifest Pharmacy
Read the full account
This is the fullest supply-chain disclosure in either of our registries. Rx.com's terms name the dispensing pharmacy, its street address, its telephone number and its opening hours: Manifest Pharmacy, 1018 S. Batesville Road, Greer, South Carolina, on 888-770-4009, weekdays from eight to five Eastern. The prescribing side is named too — MDIntegrations, with its web address — rather than introduced as an example. And then the sentence nobody else writes: you may direct your prescription to any pharmacy of your choosing, with an email address to arrange it before you order. One gap remains. Nothing says whether Manifest makes the medication to order under your prescription or dispenses it ready-made, and no individual clinician is named.
Read on the Rx.com site, September 2026.
Quality
Third-party testing, and what is published
Describes a testing regime
Nothing published on the pages searched
Certificate of analysis readable
No lot report a buyer can open
Read the full testing account
No certificate of analysis, potency, purity or sterility result appears anywhere. Its LegitScript certification is real and belongs to this domain — the certificate image loads for rx.com and an invented certificate number returns an error in the same check — which proves a certificate was issued to this site and nothing about what Manifest Pharmacy ships. The more useful thing Rx.com publishes is negative space: no patient count, no satisfaction figure, no testimonial and no before-and-after photograph on its weight-loss pages. The percentages it does shout are the discount card's, a separate business with its own terms, and they describe neither the drug nor its price.
Read on the Rx.com site, September 2026.
Licensing
Licensed to dispense, and where
Coverage
Rx.com says it has licensed providers in all 50 states, printed in the bar at the top of every page and checked on September 13, 2026. That is a claim about where its clinicians can practice rather than a promise to ship compounded medication to any particular address, and no state list appears anywhere on the site.
Read the full licensing claim
The operating company is named in the footer and the terms — Rx Platform LLC — with arbitration seated in San Francisco under JAMS rules and no state of incorporation published. The clinical network is named as MDIntegrations; no individual prescriber, medical director or advisory panel is.
Read on the Rx.com site, September 2026.
Regulatory
The FDA warning letter
Checked, and none found
Assessment
What holds up, and what does not
- It names the dispensing pharmacy with a street address, phone number and opening hours.
- It names the clinical network too — MDIntegrations — rather than describing it vaguely.
- Its terms say you may send the prescription to any pharmacy you choose, which is close to unique here.
Show 5 more
- Its GLP-1 pages carry no weight-loss percentage, no timeline and no before-and-after.
- The dose ranges it publishes match the trial ladders exactly, top and bottom, for both molecules.
- "No automatic renewals" is printed under both plans.
- Its LegitScript certification is real and belongs to this domain.
- No FDA warning letter — for Rx.com, for Rx Platform LLC, or for Manifest Pharmacy.
- No trial is named anywhere, so its one comparative claim about tirzepatide arrives with nothing to check.
- Nothing says whether Manifest Pharmacy makes the medication to order or dispenses it ready-made.
- No individual clinician is named — MDIntegrations is a network, not a person.
Show 4 more
- The discount card's "save up to 90%" shares the brand and the header with a weight-loss program it has nothing to do with.
- "For life" pricing is advertised with no explanation of what happens when the six months end.
- No certificate of analysis or batch result is published.
- No state of incorporation is given for Rx Platform LLC.
Verdict
The bottom line
On the two questions this market usually dodges — who makes it, and can I go elsewhere — Rx.com gives the fullest answers we've published. On evidence it is quiet rather than wrong: it describes the molecules accurately, gets the dose ladders right, and cites no trial at all. The one thing to be careful of is arriving from its discount card, because none of those percentages describe this program.
Opens rx.com. A link is not a recommendation to take anything.
The sentence nobody else writes
From Rx.com's own terms:
"While there may be a preferred pharmacy used, you have the ability to direct your prescription to any pharmacy of your choosing… Please email [support] if you would like to use your own pharmacy before completing your order."
We have read a lot of these documents. That sentence is close to unique.
And it isn't alone. The same terms name the pharmacy outright:
"Prescriptions ordered through the weight-loss program are dispensed by Manifest Pharmacy, 1018 S. Batesville Road, Greer, SC 29650, 888-770-4009, Monday-Friday 8:00am-5:00pm EST."
Plus the prescribing side, MDIntegrations, with its web address. Most sellers name a category and stop.
One gap: nothing says whether Manifest makes the drug to order under your prescription or dispenses it ready-made. That distinction matters, and it's missing.
Full analysis — 3 more sectionsWhat it doesn't claim · The one comparative claim · Careful where you came from
What it doesn't claim
We swept the weight-loss page and the terms on 13 September 2026 for a weight-loss percentage, a pounds figure, a timeline, a success rate, a before-and-after or a patient count.
None of them exists.
What Rx.com says about the molecules is mechanical and dose-factual:
"Works on two hormone receptors, GLP-1 and GIP."
"Your provider sets and adjusts your dose (2.5 mg to 15 mg); your price stays the same."
That second one is worth noticing. SURMOUNT-1 started participants at 2.5 mg and topped out at 15 mg. 2 The semaglutide page publishes 0.25 mg to 2.4 mg — exactly the ladder STEP 1 used, ending at the maintenance dose it measured. 1
A seller whose published dose range matches the trial is a small signal, and a good one. The usual pattern is a price pegged to a starting dose with nothing published above it.
The one comparative claim
"Produced the largest average weight loss in its clinical trials."
About tirzepatide, and among approved medicines in this class, SURMOUNT-1 supports it. 2 Note the scoping — in its clinical trials, not "of any drug ever". That's the careful version.
No trial is named, though. Nowhere on the site. So a reader has an accurate sentence and no way to verify it.
Careful where you came from
The loudest numbers on rx.com belong to something else entirely:
"Save Up To 90%" · "save up to 80% at the pharmacy with our free Rx Discount Card"
That's a prescription discount card — a separate business with separate terms, sharing the brand and the header. Those percentages describe neither this medication nor its price, and someone arriving from a coupon search is one click from a GLP-1 signup carrying the wrong expectation.
Questions
Frequently asked questions
Which pharmacy fills an Rx.com prescription?
Manifest Pharmacy, at 1018 S. Batesville Road, Greer, South Carolina, on 888-770-4009 weekdays — quoted from Rx.com's own terms, opening hours included, with the doctors' side named too as MDIntegrations. What it doesn't say is whether Manifest makes the medication to order or dispenses it ready-made.
Can I use my own pharmacy?
Rx.com says yes, which is close to unique in this market — its terms tell you to email support before ordering to arrange it. One thing to check first: the plan price includes the medication, so moving the prescription changes what you're paying for.
How much weight will I lose?
Rx.com doesn't say, anywhere. No percentage, no pounds figure, no timeline and no before-and-after appears on its weight-loss pages. That means nothing here overstates the trials, and it also means the site gives you nothing to set expectations against.
Is "the largest average weight loss" true of tirzepatide?
Among approved medicines in this class, yes — SURMOUNT-1 reported the largest mean reduction published. Rx.com scopes the sentence carefully, saying in its clinical trials rather than claiming a universal record. It names no trial, so you'd have to take it on trust from the page itself.
What about the 90% savings I saw?
That's the prescription discount card, a separate business with its own terms that happens to share the brand and the header. It has nothing to do with the GLP-1 program or its pricing. If you arrived from a coupon search, none of those percentages apply here.
Glossary
Key terms
Show definitions
- Titration
- Starting at a low dose and stepping up over weeks to a target. Both major weight-loss trials titrated participants up and measured results at the maintenance dose rather than on the way there.
- Compounded
- Made to order by a pharmacy for an individual patient rather than manufactured and approved as a finished product. Compounded drugs are not FDA-approved and the FDA has not evaluated their safety, effectiveness or quality.
- GIP
- A second gut hormone receptor. Tirzepatide acts on it as well as on the GLP-1 receptor, which is what "dual agonist" means and why its trial results differ from semaglutide's.
Compare
Others selling what Rx.com sells
Companies we have also reviewed that dispense at least one of the same compounds, ordered by how much of what they say about their products matches the trials behind them. Nothing here is a recommendation, and none of these links earns us anything.
Method
How we checked this
Non-product facts last checked September 2026. Read the editorial policy for the rules this page is held to.
Read our methodology
Claims read first-party
Every quoted claim was read off Rx.com's own pages, first-hand, on the date stamped against it — never from a summary, an aggregator, or an earlier version of this review.
Trials read from the registry
Phase, status and enrollment come from ClinicalTrials.gov; identifiers and journals from PubMed's own records. Nothing here is cited from memory.
Absence claims bounded
Where we report that no trial exists, the page says what was searched, where, and when — never an unbounded claim that nobody has tested something.
Letters matched on full name
FDA letters are matched on the complete company name. A substring match would attach one firm's regulatory history to another with a similar name.
Sources
References
Show all 2 sources
- Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) — 1,961 adults over 68 weeks, titrated from 0.25 mg to a 2.4 mg maintenance dose. New England Journal of Medicine. https://clinicaltrials.gov/study/NCT03548935
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) — 2,539 adults over 72 weeks, from a 2.5 mg start to 5, 10 and 15 mg maintenance doses. New England Journal of Medicine. https://clinicaltrials.gov/study/NCT04184622
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.